Health Services Research
Latest posts by Health Services Research (see all)
- Why We Should Not Be Indifferent to Specification Choices for Difference-in-Differences - Dec. 11, 2014
- Variations in Guideline-Concordant Breast Cancer Adjuvant Therapy in Rural Georgia - Dec. 10, 2014
- Drivers of Inpatient Hospital Experience Using the HCAHPS Survey in a Canadian Setting - Dec. 08, 2014
- Spillover Effects of the Affordable Care Act? Exploring the Impact on Young Adult Dental… - Dec. 08, 2014
Objective To compare the use of guideline-recommended prescription medications for diabetes among Medicare beneficiaries enrolled in stand-alone prescription drug plans (PDPs) with Medicare Advantage prescription drug plans (MAPDs) in the presence of potential selection bias. Data Sources/Study Setting Centers for Medicare and Medicaid Services’ Chronic Condition Data Warehouse (2006, 2007). Study Design Retrospective cross-sectional comparison of drug use and proportion of days covered (PDC) for oral-antidiabetics, ACE-inhibitors/ARBs, and antihyperlipidemics among PDP and MAPD enrollees with diabetes. We estimated nave regression models assuming exogenous plan choice and two-stage residual inclusion (2SRI) models to study endogeneity in choice of Part D plan type.
Originally posted here: